Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial surface receptors on Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii are a diverse set of proteins and glycans that facilitate the initial stages of infection, including colonization and biofilm formation. In S. aureus, these include Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) like Clumping factor A (ClfA) and Protein A (Spa), which are vital for binding host extracellular matrix proteins and evading immune detection (Foster et al., 2014, PMID: 24413161). P. aeruginosa and A. baumannii utilize surface structures such as Type IV pili, lectins (LecA/B), and outer membrane proteins (e.g., OmpA) to adhere to host cells and environmental surfaces, contributing to their persistence in clinical settings (Giraud & de Bentzmann, 2012, PMID: 22460523; Lee et al., 2017, PMID: 28163631). These receptors are primary targets for anti-virulence therapies, including monoclonal antibodies like Tefibazumab and MEDI3902, which aim to block bacterial attachment or promote clearance by the immune system (DiGiandomenico et al., 2014, PMID: 25393894). By targeting these surface-exposed molecules, researchers hope to develop treatments that reduce the severity of infections such as pneumonia and sepsis while minimizing the selective pressure that drives antibiotic resistance.
Inhibition of bacterial adhesion to host tissues, neutralization of surface-associated virulence factors, and enhancement of opsonophagocytic killing by the host immune system.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial surface receptors of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii.